We are live on
!
Find out more
AA
AlphaMark Advisors Portfolio holdings
AUM
$231M
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter
Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
(+3.6%)
Cap. Flow
-$5.16M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.15M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.48M |
| 3 |
Dollar Tree
DLTR
|
+$1.94M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$857K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$833K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$4.4M |
| 2 |
EOG Resources
EOG
|
+$2.91M |
| 3 |
United Therapeutics
UTHR
|
+$2.5M |
| 4 |
Zebra Technologies
ZBRA
|
+$1.98M |
| 5 |
PVH
PVH
|
+$1.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.55% |
| 2 | Consumer Staples | 7.28% |
| 3 | Technology | 6.91% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Industrials | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMCP
1
DELISTED
AlphaMark Actively Managed Small Cap ETF
SMCP
| $21.6M | 9.03% |
855,589
+12,344
| +1% | +$297K |
|
2
iShares Russell 2000 Value ETF
IWN
$14.3B
| $13.9M | 5.8% |
107,786
-5,986
| -5% | -$740K |
|
3
Procter & Gamble
PG
$336B
| $7.12M | 2.98% |
57,022
-599
| -1% | -$73.3K |
|
4
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.17B
| $7.08M | 2.97% |
209,735
+3,422
| +2% | +$114K |
|
|
IBDN
5
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $6.69M | 2.8% |
264,705
+4,766
| +2% | +$121K |
|
6
Global Payments
GPN
$23B
| $6.27M | 2.63% |
34,369
-2,088
| -6% | -$358K |
|
|
7
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $5.75M | 2.41% |
17,855
+2,705
| +18% | +$833K |
|
8
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $5.54M | 2.32% |
179,577
+11,450
| +7% | +$353K |
|
9
Ross Stores
ROST
$80.5B
| $5.12M | 2.14% |
43,996
-476
| -1% | -$53.6K |
|
10
Intercontinental Exchange
ICE
$85.6B
| $4.88M | 2.04% |
52,672
-1,864
| -3% | -$173K |
|
11
Estee Lauder
EL
$30.4B
| $4.83M | 2.02% |
23,384
-572
| -2% | -$111K |
|
12
Marathon Petroleum
MPC
$92.4B
| $4.66M | 1.95% |
77,407
-1,135
| -1% | -$71K |
|
13
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $4.33M | 1.81% |
85,020
+11,656
| +16% | +$594K |
|
|
FITB
14
Fifth Third Bancorp
FITB
$51.2B
| $4.29M | 1.79% |
139,458
+928
| +0.7% | +$27.2K |
|
15
Marriott International
MAR
$98.3B
| $4.13M | 1.73% |
27,251
-888
| -3% | -$119K |
|
16
Goldman Sachs
GS
$300B
| $4.12M | 1.73% |
17,937
+70
| +0.4% | +$15.2K |
|
17
Verizon
VZ
$195B
| $4.03M | 1.69% |
65,687
+216
| +0.3% | +$13K |
|
18
Packaging Corp of America
PKG
$21.9B
| $3.91M | 1.64% |
34,937
+258
| +0.7% | +$28.5K |
|
19
Amphenol
APH
$198B
| $3.87M | 1.62% |
143,008
-1,748
| -1% | -$44.6K |
|
20
Waste Management
WM
$90.6B
| $3.85M | 1.61% |
33,773
-952
| -3% | -$108K |
|
21
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$349M
| $3.71M | 1.55% |
82,080
-4,560
| -5% | -$199K |
|
|
FLG
22
Flagstar Bank National Association
FLG
$5.93B
| $3.6M | 1.51% |
99,983
+1,783
| +2% | +$65.8K |
|
23
Western Alliance Bancorporation
WAL
$8.79B
| $3.56M | 1.49% |
62,422
+661
| +1% | +$33.8K |
|
24
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $3.47M | 1.45% |
16,185
-1,138
| -7% | -$231K |
|
25
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| $3.38M | 1.41% |
63,003
+2,452
| +4% | +$126K |
|
Similar funds
AJ
MWS
LHR
HPFG
GWM
KC
SL
CSWM
AlphaMark Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.
- AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
- AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
- AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
- AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
- AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
- AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
- AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.
Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.